Summary by Ground NewsHTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper. The White Paper describes the use of HTG’s Transcriptome Panel (HTP) in early-stage design, selection and characterization of small-molecule candidates.
1 month ago·Tucson, United States
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Time & Location
Sources are mostly out of (0)
No sources with tracked biases.
See less detail